A Safety and Efficacy Study of DRM02 in Subjects With Plaque Psoriasis
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DRM02 is safe and effective in the
treatment of plaque psoriasis when applied twice daily for 6 weeks.